Compile Data Set for Download or QSAR
maximum 50k data
Found 296 Enz. Inhib. hit(s) with all data for entry = 474
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270883(7-(benzenesulfonyl)-4-(cyclohex-1-en-1-yl)-5H-pyrr...)
Affinity DataEC50:  5.50E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270884(3-(benzenesulfonyl)-N-(4,4-difluorocyclohexyl)-1H-...)
Affinity DataEC50:  21nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270885(7-(benzenesulfonyl)-4-cyclohexyl-5H-pyrrolo[3,2-d]...)
Affinity DataEC50:  43nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270886(4-cyclohexyl-7-[(4-methoxybenzene)sulfonyl]-5H-pyr...)
Affinity DataEC50:  25nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270887(4-(cyclohex-1-en-1-yl)-7-[(4-methoxybenzene)sulfon...)
Affinity DataEC50:  80nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270888(7-(benzenesulfonyl)-4-(morpholin-4-yl)-5H-pyrrolo[...)
Affinity DataEC50:  273nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270889(7-(2-fluorobenzenesulfonyl)-2-methyl-4-(2,2,3-trim...)
Affinity DataEC50:  47nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270890(7-(benzenesulfonyl)-4-(piperidin-1-yl)-5H-pyrrolo[...)
Affinity DataEC50:  3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270891(7-(benzenesulfonyl)-4-phenyl-5H-pyrrolo[3,2-d]pyri...)
Affinity DataEC50:  48nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270892(7-(benzenesulfonyl)-4-[(E)-2-cyclopropylethenyl]-5...)
Affinity DataEC50:  626nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270893(3-(benzenesulfonyl)-6-chloro-1H-pyrrolo[3,2-b]pyri...)
Affinity DataEC50:  112nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270894(7-(benzenesulfonyl)-4-(prop-1-en-2-yl)-5H-pyrrolo[...)
Affinity DataEC50:  355nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270895(6-amino-4-(cyclohex-1-en-1-yl)-N-(4-methoxyphenyl)...)
Affinity DataEC50:  267nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270896(7-(benzenesulfonyl)-4-(2-cyclopropylethyl)-5H-pyrr...)
Affinity DataEC50:  2.58E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270897(7-(benzenesulfonyl)-4-(propan-2-yl)-5H-pyrrolo[3,2...)
Affinity DataEC50:  1.06E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270898(7-(benzenesulfonyl)-4-(3-methoxypyrrolidin-1-yl)-5...)
Affinity DataEC50:  21nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270899(3-(benzenesulfonyl)-7-(cyclohex-1-en-1-yl)-1H-pyrr...)
Affinity DataEC50:  5.09E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270900(3-(benzenesulfonyl)-7-(cyclohex-1-en-1-yl)-1H-pyrr...)
Affinity DataEC50:  528nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270901(4-(cyclohex-1-en-1-yl)-7-(pyridine-2-sulfonyl)-5H-...)
Affinity DataEC50:  28nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270902(7-(benzenesulfonyl)-4-(cyclohex-1-en-1-yl)-2-methy...)
Affinity DataEC50:  317nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270903(7-[(4-chlorobenzene)sulfonyl]-4-(cyclohex-1-en-1-y...)
Affinity DataEC50:  54nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270904(7-(benzenesulfonyl)-4-cyclopentyl-5H-pyrrolo[3,2-d...)
Affinity DataEC50:  73nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270905(7-(benzenesulfonyl)-4-(cyclopent-1-en-1-yl)-5H-pyr...)
Affinity DataEC50:  97nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270906(7-(benzenesulfonyl)-4-(4,4-difluoropiperidin-1-yl)...)
Affinity DataEC50:  19nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270907(4-(cyclohex-1-en-1-yl)-7-[(4-fluorobenzene)sulfony...)
Affinity DataEC50:  288nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270908(3-(benzenesulfonyl)-6-(cyclohex-1-en-1-yl)-1H-pyrr...)
Affinity DataEC50:  46nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270909(4-cyclohexyl-7-[(4-fluorobenzene)sulfonyl]-5H-pyrr...)
Affinity DataEC50:  89nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270910(7-(benzenesulfonyl)-4-(3,3-difluoropyrrolidin-1-yl...)
Affinity DataEC50:  647nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270911(7-(benzenesulfonyl)-4-(4-methoxypiperidin-1-yl)-5H...)
Affinity DataEC50:  399nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270912(4-(azetidin-1-yl)-7-(benzenesulfonyl)-5H-pyrrolo[3...)
Affinity DataEC50:  9.53E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270913(3-(benzenesulfonyl)-7-cyclohexyl-1H-pyrrolo[3,2-c]...)
Affinity DataEC50:  720nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270914(7-(benzenesulfonyl)-4-(pyrrolidin-1-yl)-5H-pyrrolo...)
Affinity DataEC50:  37nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270915(4-(cyclohex-1-en-1-yl)-7-{[4-(difluoromethoxy)benz...)
Affinity DataEC50:  52nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270916(7-(benzenesulfonyl)-4-cyclohexyl-N-methyl-5H-pyrro...)
Affinity DataEC50:  89nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270917(7-(benzenesulfonyl)-4-(3,3-difluoropiperidin-1-yl)...)
Affinity DataEC50:  7.52E+3nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270918(4-cyclohexyl-7-{[4-(difluoromethoxy)benzene]sulfon...)
Affinity DataEC50:  87nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270919(4-(cyclohex-1-en-t-yl)-7-[(2-fluorobenzene)sulfony...)
Affinity DataEC50:  80nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270920(4-(cyclohex-1-en-1-yl)-7-[(3-fluorobenzene)sulfony...)
Affinity DataEC50:  16nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270921(4-cyclohexyl-7-[(3-fluorobenzene)sulfonyl]-5H-pyrr...)
Affinity DataEC50:  80nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270922(7-(benzenesulfonyl)-4-(cyclohex-1-en-1-yl)-2-ethyl...)
Affinity DataEC50:  55nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270923(7-(benzenesulfonyl)-4-cyclohexyl-2-methyl-5H-pyrro...)
Affinity DataEC50:  37nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270924(4-(cyclohex-1-en-1-yl)-7-[(4-methylbenzene)sulfony...)
Affinity DataEC50:  32nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270925(4-cyclohexyl-7-(6-methoxypyridine-3-sulfonyl)-5H-p...)
Affinity DataEC50:  78nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270926(4-(cyclohex-1-en-1-yl)-7-(6-methoxypyridine-3-sulf...)
Affinity DataEC50:  173nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270927(4-cyclohexyl-7-[(4-methylbenzene)sulfonyl]-5H-pyrr...)
Affinity DataEC50:  84nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270928(7-(benzenesulfonyl)-4-(3,3-dimethylpyrrolidin-4-yl...)
Affinity DataEC50:  153nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270929(7-(benzenesulfonyl)-4-(4-fluoropiperidin-1-yl)-5H-...)
Affinity DataEC50:  358nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270930(4-(azepan-1-yl)-7-(benzenesulfonyl)-5H-pyrrolo[3,2...)
Affinity DataEC50:  209nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270931(4-(cyclohex-1-en-1-yl)-7-(cyclohexanesulfonyl)-5H-...)
Affinity DataEC50:  113nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFree fatty acid receptor 2(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM270932(4-(cyclohex-1-en-1-yl)-7-[(3,4-difluorobenzene)sul...)
Affinity DataEC50:  80nMAssay Description:GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 296 total ) | Next | Last >>
Jump to: